BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Mallinckrodt
Fuji
Novartis
Colorcon
Argus Health
Chinese Patent Office
Teva
Farmers Insurance

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,997,903

« Back to Dashboard

Which drugs does patent 5,997,903 protect, and when does it expire?

Patent 5,997,903 protects PROTONIX and is included in one NDA.

Protection for PROTONIX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-six patent family members in thirty-three countries.
Summary for Patent: 5,997,903
Title: Oral-administration forms of a medicament containing pantoprazol
Abstract:The invention relates to oral presentation forms for pantoprazole, which consist of a core, an intermediate layer and an outer layer which is resistant to gastric juice.
Inventor(s): Dietrich; Rango (Constance, DE), Ney; Hartmut (Constance, DE)
Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH (Konstanz, DE)
Application Number:08/167,961
Patent Claim Types:
see list of patent claims
Dosage form; Composition; Compound;

Drugs Protected by US Patent 5,997,903

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Wyeth Pharms Inc PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987-002 Jun 12, 2001 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc PROTONIX pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 020987-001 Feb 2, 2000 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,997,903

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland788/91Jun 17, 1991
PCT Information
PCT FiledJune 13, 1992PCT Application Number:PCT/EP92/01341
PCT Publication Date:December 23, 1992PCT Publication Number: WO92/22284

International Patents Family Members for US Patent 5,997,903

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 144416 ➤ Subscribe
Australia 1974692 ➤ Subscribe
Australia 683411 ➤ Subscribe
Bulgaria 61796 ➤ Subscribe
Bulgaria 98286 ➤ Subscribe
Canada 2109697 ➤ Subscribe
Canada 2524168 ➤ Subscribe
China 1037932 ➤ Subscribe
China 1067809 ➤ Subscribe
Czech Republic 281697 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Mallinckrodt
McKesson
Teva
Express Scripts
Chubb
Fuji
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot